Excess mortality in the Republic of Sakha (Yakutia) during the COVID-19 pandemic (2020-2021)
https://doi.org/10.25789/YMJ.2022.80.19
Abstract
Excess mortality is defined as an increase in all-cause mortality over expected mortality (historical baseline for previous years). In the context of COVID-19, excess mortality may reflect the overall impact of the pandemic on mortality, including not only the number of confirmed deaths from COVID-19, but also deaths from COVID-19 when they were not correctly diagnosed and reported, and deaths from other diseases due to pandemic-related causes.
The purpose of the study: to assess the indicators of excess mortality during the COVID-19 pandemic (2020-2021) in the Republic of Sakha (Yakutia). For the analysis, data from the Federal State Statistics Service for 2015-2022 were used. For 2 years of the spread of a new coronavirus infection in the Republic of Sakha (Yakutia), 19556 people died. 7.8% of deaths in 2020 and 21.5% in 2021 were related to COVID-19. The number of all deaths was 22% and 44% respectively higher than the expected number of deaths. The proportion of excess deaths in 2020 was 19% of all deaths, in 2021 - 31%. Of the excess deaths, 42% and 69%, respectively, were related to COVID-19. The excess mortality rate reached 333 per 100,000 population in 2021. The high correlation coefficients (0.94-0.95) between COVID-19-related deaths and additional deaths suggest that excess deaths during the period 2020-2021 will largely be due to the spread of COVID-19.
The decline in mortality underreporting in 2021 against the background of an increase in excess mortality reflects improved diagnosis and correct identification of the causes of death. Research into the causes of excess mortality is needed to assess the impact of the pandemic and other factors on various aspects of mortality in the population
About the Authors
T. M. Klimova
M.K. Ammosov North-Eastern Federal University;
Yakut Science Center of Complex Medical Problems
Russian Federation
Russian Federation
Klimova Tatyana Mikhailovna – PhD in Medicine, Associate Professor, Department of Pharmacology and Pharmacy, Medical Institute of the M.K. Ammosov North-Eastern Federal University, Senior Researcher, Department of Epidemiology of Chronic Non-Communicable Diseases, Yakut Science Center of Complex Medical Problems
A. A. Kuzmina
M.K. Ammosov North-Eastern Federal University
Russian Federation
Russian Federation
Kuzmina Ariana Afanasevna – PhD in Pharmaceutics, Head of Department of Pharmacology and Pharmacy at Medical Institute
L. K. Turkebaeva
M.K. Ammosov North-Eastern Federal University
Russian Federation
Russian Federation
Turkebaeva Lena Kimovna – PhD in Biology, Associate Professor, Department of Pharmacology and Pharmacy, Medical Institute
I. Sh. Malogulova
M.K. Ammosov North-Eastern Federal University
Russian Federation
Russian Federation
Malogulova Irina Shamilyevna – PhD in Biology, Associate Professor, Department of Pharmacology and Pharmacy at Medical Institute
References
1. Goroshko N.V., Patsala S. V. Izbytochnaya smertnost' v period pandemii COVID-19: regiony Rossii na fone strany [Excess mortality during the COVID-19 pandemic: russian regions against the backdrop of the country]. Social'notrudovye issledovaniya [Social and Labour Research. 2022; 46 (1): 103-116 ( In Russ.).] DOI: 10.34022/2658-3712-2022-46-1-103-116.
2. Kashepov A.V. Kovidnyj mul'tiplikator smertnosti ili novyj metodicheskij podhod k analizu izbytochnoj smertnosti naseleniya v 20202021 gg. [COVID mortality multiplier and a new methodological approach to the analysis of excess mortality in 2020-2021]. Social'no-trudovye issledovaniya [Social and Labour Research [Federal'naya sluzhby gosudarstvennoj statistiki. Arhiv operativnyh dannyh po EDN (In Russ.).] https://rosstat.gov.ru/storage/mediabank/edn_03-2022.htm
3. Federal State Statistics Service. Archive of operational data on vital statistics. https://rosstat.gov.ru/storage/mediabank/edn_03-2022.htm (In Russ.).]
4. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. COVID-19 Excess Mortality Collaborators // Lancet (London, England). 2022; 399(10334): 1513-1536. doi.org/10.1016/S0140-6736(21)02796-3
5. Beaney T, Clarke J. M., Jain V [et al.] Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? Journal of the Royal Society of Medicine. 2020; 113 (9): 329334. DOI: 10.1177/0141076820956802
6. Karlinsky A., Kobak D. Tracking excess mortality across countries during the covid-19 pandemic with the world mortality dataset. eLife. 2021; 10: 1-21. DOI: https://doi.org/10.7554/eLife.69336
7. R. Beelen, G. Hoek, P. A. van den Brandt [et al.] Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environmental Health Perspectives. 2008; 116 (2): 196-202. doi:10.1289/ehp.10767
8. WHO. COVID-19 significantly impacts health services for noncommunicable diseases. https://www.who.int/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases
9. – World Health organization. Health Effects of Particulate Matter. Policy implications for countries in eastern Europe, Caucasus and central Asia. / World Health organization. – 2013. 15 p. https://www.euro.who.int/data/assets/pdf_file/0006/189051/Health-effects-of-particulate-matter-final-Eng.pdf
Review
For citations:
Klimova T.M., Kuzmina A.A., Turkebaeva L.K., Malogulova I.Sh. Excess mortality in the Republic of Sakha (Yakutia) during the COVID-19 pandemic (2020-2021). Yakut Medical Journal. 2022;(4):71-74. https://doi.org/10.25789/YMJ.2022.80.19
Views:
41
Email this article 